Equities

Microbot Medical Inc

Microbot Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.891
  • Today's Change0.011 / 1.26%
  • Shares traded80.76k
  • 1 Year change-42.14%
  • Beta1.7018
Data delayed at least 15 minutes, as of Apr 24 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.

  • Revenue in USD (TTM)0.00
  • Net income in USD-10.74m
  • Incorporated1988
  • Employees22.00
  • Location
    Microbot Medical Inc25 RECREATION PARK DR SUITE 108HINGHAM 02043United StatesUSA
  • Phone+1 (908) 938-5561
  • Fax+1 (302) 655-5049
  • Websitehttp://www.microbotmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pioneer Green Farms Inc9.29k-403.37k11.94m6.00------1,285.15-0.0172-0.01720.0004-0.0260.01540.3035--1,548.33-66.94------41.44---4,341.98--0.0106-30.89--------35.41------
Coeptis Therapeutics Holdings Inc0.00-21.27m12.09m5.00--2.74-----0.8922-0.89220.000.12210.00----0.00-266.05-36.90-392.90-37.81------------0.2068------43.40------
Endexx Corp4.64m6.93m12.10m--1.80--2.042.610.01330.01330.0091-0.02550.67734.3713.54--86.51------28.73--127.74--0.0664------228.66--28.26------
Viaderma Inc17.80m2.31m12.16m75.000.00060.000042.250.683116.8416.84129.62255.590.412624.691.21237,331.305.36--6.53--28.90--12.99--2.075.660.1718---29.15---40.70------
Enzolytics Inc0.00-119.19k12.42m2.00---------0.106-0.1060.00-1.040.00-------369.52-----------------4.30-----100.00---9.35------
Imunon Inc0.00-19.51m12.50m33.00--0.9338-----2.17-2.170.001.420.00----0.00-59.23-50.18-80.53-60.27-------5,725.88----0.00---100.00--45.64--26.69--
Microbot Medical Inc0.00-10.74m12.67m22.00--2.29-----1.08-1.080.000.38450.00----0.00-120.24-53.28-178.87-62.65------------0.00------18.44---31.76--
Mira Pharmaceuticals Inc0.00-11.98m12.98m3.00--2.97-----0.8314-0.83140.000.2960.00----0.00-413.86---620.46-------------2.470.00-------69.77------
Tonix Pharmaceuticals Holding Corp7.77m-116.66m13.25m103.00--0.0871--1.71-8.62-8.620.45721.800.0409----75,417.48-61.38-59.46-68.01-65.9238.97---1,501.78-5,126.731.81--0.0779------0.1874--320.57--
Check Cap Ltd0.00-17.62m13.39m85.00--0.489-----3.01-3.010.004.680.00----0.00-44.86-58.80-48.21-66.41------------0.00-------11.08--16.04--
NanoViricides Inc0.00-9.36m13.43m7.00--1.16-----0.8004-0.80040.000.98280.00----0.00-55.47-43.54-57.90-46.29------------0.00-------5.94---8.90--
Avalo Therapeutics Inc1.93m-31.54m13.44m19.00--1.43--6.98-381.36-381.366.949.110.0708128.501.87101,315.80-116.06-99.64-228.35-154.4233.2584.69-1,638.65-613.581.82-5.670.00---89.34-22.8324.28---22.48--
Lotus Pharmaceuticals Inc70.79m1.72m13.47m233.000.09040.00143.490.19030.05530.05532.563.580.632137.2717.85303,836.901.5522.841.7126.4035.1041.622.4519.930.442830.800.05160.0028.7131.70-12.2251.1170.48--
Data as of Apr 24 2024. Currency figures normalised to Microbot Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

9.90%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2023456.58k3.17%
Armistice Capital LLCas of 31 Dec 2023300.00k2.08%
BlackRock Fund Advisorsas of 31 Dec 2023137.81k0.96%
Renaissance Technologies LLCas of 31 Dec 2023106.00k0.74%
Alphacentric Advisors LLCas of 31 Dec 2023100.00k0.69%
Contego Capital Group, Inc.as of 29 Dec 2023100.00k0.69%
Geode Capital Management LLCas of 31 Dec 202392.40k0.64%
HRT Financial LLCas of 31 Dec 202357.94k0.40%
Virtu Americas LLCas of 31 Dec 202342.05k0.29%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 202333.04k0.23%
More ▼
Data from 29 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.